CD8A and neoplasm: It has been found that mouse STEAP (mSTEAP)-based vaccination can induce a specific CD8 T cell response to newly defined mSTEAP epitopes and prolong the survival rate of tumor-challenged mice, showing that vaccination against mSTEAP is a feasible option to delay tumor growth (Garcia-Hernandez Mde et al., 2007).